MedTrace Logo

PET-CT Predicting Lymph Nodes Metastasis

NCT05970913 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2026-03-23

No results posted yet for this study

Summary

This study is a single-center prospective clinical study that aims to evaluate the predictive value of preoperative 18F-FDG-PET-CT and 18F-FAPI-PET/CT for lymph node metastasis in patients with non-small cell lung cancer. The final pathological results were used to assess the predictive value of PET-CT for lymph node metastasis.

Conditions

  • Non Small Cell Lung Cancer
  • Lymph Node Metastasis
  • Positron Emission Tomography

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2026-03-28
Completion
2026-03-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05970913 on ClinicalTrials.gov